financetom
Business
financetom
/
Business
/
Blackbaud Insider Sold Shares Worth $567,096, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blackbaud Insider Sold Shares Worth $567,096, According to a Recent SEC Filing
Nov 15, 2024 12:59 PM

05:42 PM EST, 11/14/2024 (MT Newswires) -- Kevin P. Gregoire, Executive Vice President, Chief Operating Officer, on November 12, 2024, sold 6,619 shares in Blackbaud ( BLKB ) for $567,096. Following the Form 4 filing with the SEC, Gregoire has control over a total of 99,096 shares of the company, with 99,096 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1280058/000157856324000443/xslF345X05/wk-form4_1731623931.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Department store operator Macy's to close certain stores across US
Department store operator Macy's to close certain stores across US
Jan 9, 2025
Jan 9 (Reuters) - Department store operator Macy's said on Thursday it will close 66 non-go-forward store locations as part of a strategy it announced last year. (Reporting by Vallari Srivastava in Bengaluru) ...
Boeing donating $1 million to Trump presidential inaugural fund, spokesperson says
Boeing donating $1 million to Trump presidential inaugural fund, spokesperson says
Jan 9, 2025
WASHINGTON (Reuters) - Boeing is donating $1 million to U.S. President-elect Donald Trump's inauguration, a spokesperson for the U.S. planemaker said on Thursday. Boeing is joining many major U.S. companies including General Motors, Ford, Microsoft and Meta in donating for the Jan. 20 event. The planemaker previously donated $1 million to the last three presidential inaugurations, including Trump's first in...
Aptose Biosciences Initiates Dosing in Early Study of Acute Myeloid Leukemia Treatment
Aptose Biosciences Initiates Dosing in Early Study of Acute Myeloid Leukemia Treatment
Jan 9, 2025
04:26 PM EST, 01/09/2025 (MT Newswires) -- Aptose Biosciences ( APTO ) dosed the first set of patients in the phase 1/2 study of tuspetinib in combination with venetoclax and azacitidine in patients newly diagnosed with acute myeloid leukemia. Patient enrollment is expected to be 18 to 24 in mid- to late 2025, the company said Thursday in a statement....
Gatos Silver Reports 2024 Production at the Top End of Guidance
Gatos Silver Reports 2024 Production at the Top End of Guidance
Jan 9, 2025
04:24 PM EST, 01/09/2025 (MT Newswires) -- Gatos Silver ( GATO ) after close of trade Thursday reported 2024 production for its 70%-owned Cerro Los Gatos (CLG) mine in Mexico. Silver production was at the top end of the 2024 guidance range and silver equivalent production was slightly above the top end of the 2024 guidance range, according to the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved